The Latest
-
ASX 200 drops 0.4%, Chinese threat to Australian iron
-
If you invested $10,000 in the Kogan IPO, this is how much you’d have now
-
Why the share price of this top dividend share just sank 6%
-
AstraZeneca gets first supply deals for COVID vaccine, eyes late stage trials